The first physical practice guide for stereotactic radiation therapy of chinese tumors has been published.

During the 14th Annual Meeting of the Chinese Medical Association in The Rustology of Radiological Oncology (CSTRO), Varian Medical released the "Physical Practice Guide for Varian Chinese Oncology Stereotactic Radiation Therapy" and the "Consensus of The Experts in The Management of Tumor Movement sorhereating Radiation Therapy of varian China."
the Guide and Consensus were drafted by medical physics experts from six authoritative cancer centers in the field of tumor radiation therapy in China, and more than 70 medical physics experts and clinical experts from 24 well-known radiation cancer centers participated in the formulation, with the goal of promoting the development of China's tumor stereotactic radiation therapy technology from the initial stage to standardization.Professor Yu Jinming, a member of the Chinese Academy of Engineering and director of Shandong Cancer Hospital, stressed that the medical physics team plays a vital role in safeguarding the clinical work of radiation therapy, especially stereotactic radiosurgery.
For the promotion of stereotactic radiosurgery standardization, the Chinese Medical Association of radiation oncology treatment credit committee chairman Professor Wang Green suggested that on the basis of physical guidance to further integrate with the clinical.Dai Jianrong, head of the
Guide Drafting Expert Group and director of radiotherapy department of the Oncology Hospital of the Chinese Academy of Medical Sciences, said that the Guide fully considers the development of China's radiotherapy industry, which can be implemented and achievable under the existing conditions in China.Professor Zhang Fuquan, director of radiotherapy department at Beijing Concord Hospital,
, believes that in recent years, radiotherapy technology, represented by stereotactic radiosurgery, has higher application value for early tumors and non-surgical patients (including elderly patients), and has become a clinical recommendation for the treatment of early non-small cell lung cancer/intracranial metastatic tumors, and has played an important role in the treatment of metastatic tumors, liver cancer, pancreatic cancer, prostate cancer and other cancers.
"From the point of view of health economics, we should vigorously promote the popularization of this advanced technology in China". Wu Wei, director of radiology at Peking University Cancer Hospital, said that in terms of patient experience, shortening the course of treatment will be extremely convenient for the patient himself and his family. However, due to the gap in the level of physical practice, there is still a certain gap in the completion of radiotherapy technology in our hospitals. Qiu Jie, director of radiotherapy physics at Beijing Concord Hospital, said that the more complex the technology, the more physical assurance is the basis for everything, so the normative nature of physical practice is crucial in radiotherapy. In the field of stereotactic radiation therapy, which represents the direction of radiotherapy development, there has been no normative guide suitable for China's national conditions.Huang Xiaoyan, deputy director of radiotherapy at Sun Yat-sen University's Cancer Prevention center in
, said: "Oncology radiation therapy is a team battle, including radiotherapists, medical physiotherapists and therapists. Physicists are also a major force in setting norms, processes, and protocols. "
, Huaxi Hospital Radiophysics Technology Center physics director of the field of physics, said: "China is in the initial stage of stereotactic radiation therapy, the introduction of the guide not only has the guiding significance of physical practice, but also for the next step to develop clinical guidelines laid a foundation." "This joint action has served as a good demonstration to improve the practice level of cancer radiation therapy in China, " said Yu Yong, director of radiology physics at Shandong Cancer Hospital. Shandong is a radiotherapy province, this guide will improve the level of advanced radiation treatment in primary hospitals play a positive role. "As a global leader in oncology radiation therapy technologies and solutions, Varian is fully aware of the urgency and enormity of China's anti-cancer task," said Dr. Zhang Xiao, Global Vice President and President of Greater China,
as the lead and support unit for the development of the guidelines. To this end, we unite the Chinese cancer treatment industry elite, actively seek solutions to promote the standardized development of advanced radiotherapy technology in China. " (Yang Yakin)
.